Study for the Treatment of Intermittent Allergic Rhinitis With Desloratadine (Study P04683)

NCT00406783 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

547

Enrollment

INDUSTRY

Sponsor class

Conditions

Rhinitis, Allergic, Seasonal
Rhinitis, Allergic, Perennial

Interventions

DRUG: 5-mg Desloratadine
DRUG: Placebo

Sponsor

Organon and Co